Financials
Financial year 2024
LENAPHARM PHARMACIE from Elsene, company number BE0880705956, closed financial year 2024 with a result of € 47,549 after tax. For that financial year LENAPHARM PHARMACIE recorded a gross margin of € 151,233 and equity of € 512,274. Compared with financial year 2023, the result moved from € 136,404 to € 47,549. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 18, 2025.
€ 512,274
▲ 10% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 47,549
▼ 65% vs 2023
Profit after tax over the fiscal year.
€ 2,129
▼ 95% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 499,874.
People and assets in 2024
€ 16,670
▲ 2% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 200,172
▼ 11% vs 2023
€ 20,142 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 440,417
▼ 46% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 84,431
▼ 14% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 115,305 | € 210,976 | € 241,201 | € 151,233 | ▼ 37% |
| Profit after taxes | € 62,964 | € 114,286 | € 136,404 | € 47,549 | ▼ 65% |
| Equity | € 279,035 | € 328,321 | € 464,725 | € 512,274 | ▲ 10% |
| Total debts | € 1,097,663 | € 795,867 | € 1,141,222 | € 1,043,707 | ▼ 9% |
| Cash | € 52,095 | € 1,925 | € 40,871 | € 2,129 | ▼ 95% |
| Land & buildings | € 173,084 | € 196,157 | € 178,017 | € 159,876 | ▼ 10% |
| Retained profit | € 266,635 | € 315,921 | € 452,325 | € 499,874 | ▲ 11% |
| Dividend | € 0 | € 65,000 | € 0 | € 0 | |
| Bank debt | € 309,899 | € 256,411 | € 224,726 | € 200,172 | ▼ 11% |
| Balance sheet total | € 1,376,698 | € 1,124,188 | € 1,605,947 | € 1,555,981 | ▼ 3% |
Key figures of LENAPHARM PHARMACIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to LENAPHARM PHARMACIE?
What happened at LENAPHARM PHARMACIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 47,549 (▼ 65% vs 2023). filed late Source: NBB ↗
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 62,964 profit in 2021 to € 47,549 profit in 2024.
Paid € 158,555 in corporate taxes since 2021.
Best year ever: 2023, with € 136,404 profit.
Paid out € 65,000 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Generaal Jacqueslaan 42 box 1
1050 Elsene
Pastoor Cuylitsstraat 2
1070 Anderlecht
Active since 27 April 2006
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0880.705.956
- VAT number
- BE 0880.705.956
- Registered office
- Generaal Jacqueslaan 42 bus 1, 1050 Elsene
- Names & denominations
- LENAPHARM PHARMACIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 April 2006
- Peppol
- Active · Active since 14 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers